** Insurer Lemonade Inc's shares jump as much as 13%, last up 10.6% to $44.44
** Morgan Stanley upgrades company's shares to "equal-weight" from "underweight"; raises PT to $42 from $23
** Company's shares closed up 17% on Tuesday after LMND's investor day
** Company at its investor day unveiled plan to grow its business from $1 bln in premiums to $10 bln over the next few years
** Morgan Stanley says that while LMND's targets are ambitious, management outlined specific strategies on how to achieve the growth targets
** Brokerage adds the most important element of the investor day for it was the goal to achieve net profit exiting 2027, which is significantly better than Wall Street consensus and its expectations
** 1 of 10 brokerages rate the stock "buy", 6 "hold" and 3 "sell" or lower; median PT $21 - LSEG
** As of last close, LMND shares more than doubled YTD
(Reporting by Arasu Kannagi Basil in Bengaluru) ((ArasuKannagi.Basil@thomsonreuters.com))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。